Antibiotic resistance in Helicobacter pylori: Is it a problem in New Zealand?

New Zealand Medical Journal

Volumn 117, Issue 1200, 2004, Pages

  Ahmed, Dilruba ^a   Brooks, Heather ^a   McConnell, Michelle ^b   Barbezat, Gil ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AWARENESS; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NEW ZEALAND; NONHUMAN; PATIENT SELECTION; PHYSICIAN; PUBLIC HOSPITAL; QUANTITATIVE ANALYSIS; STOMACH BIOPSY; UPPER GASTROINTESTINAL TRACT; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STOMACH;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; NEW ZEALAND; STOMACH;

EID: 16544390919     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol. 2000;54:615-40.
2. Fraser AG, Scragg R, Metcalf P, et al. Prevalence of Helicobacter pylori infection in different ethnic groups in New Zealand children and adults. Aust NZ J Med. 1996;26:646-51.
3. Fawcett JP, Shaw JP, Brooke M, et al. Seroprevalence of Helicobacter pylori in a longitudinal study of New Zealanders ages 11-21. Aust N Z J Med. 1998;28:585-9.
4. Collett JA, Burt MJ, Frampton CM, et al. Seroprevalence of Helicobacter pylori in the adult population of Christchurch: risk factors and relationship to dyspeptic symptoms and iron studies. N Z Med J. 1999;112:292-5.
5. Alarcon T, Domingo D, Lopez-Brea M. Antibiotic resistance problems with Helicobacter pylori. Int J Antimicrob Ag 1999;12:19-26.
6. Qasim A, Morain CA. Review article: treatment of Helicobacter pylori infection and factors influencing eradication. Aliment Pharmacol Ther. 2002;16 Suppl 1:24-30.
7. Kearney DJ. Retreatment of Helicobacter pylori infection after initial treatment failure. Am J Gastroenterol. 2001;96:1335-9.
8. Glupczynski Y, Megraud F, Lopez-Brea M, Andersen LP. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis. 2001;20:820-5.
9. Van der Wouden E. J. Review article: nitroimidazole resistance in Helicobacter pylori. Aliment Pharmacol Ther. 2000;14:7-14.
10. Miki I, Aoyama N, Sakai T, et al. Impact of clarithromycin resistance and CYP2CI9 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan. Eur Gastroenterol Hepatol. 2003;15:27-33.
11. Fraser AG, Moore L, Ali MR, et al. An audit of low dose triple therapy for eradication of Helicobacter pylori. N Z Med J 1996;109:290-2.
12. Fraser AG, Hackett M, Moore L, Hollis B. Helicobacter treatment and antibiotic susceptibility: results of a five year audit. Aust N Z J. 1999;29:512-6.
13. New Zealand Handbook. Microbiological surveillance of flexible hollow endoscopes. SNZ HB 8149. Wellington: Ministry of Health; 2001
14. Goodwin S. Detection of Helicobacter pylori infection by biopsy urease, histology, and culture. In Clayton CL, Mobley HLT, editor. Methods in Molecular Medicine. Totowa, New Jersey: Humana Press; 1997. p7-18.
15. Grove DI, Koutsouridis G. Increasing resistance of Helicobacter pylori to clarithromycin: is the horse bolting? Pathol. 2002;34:71-3.
16. Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther. 1997;11 Suppl 1:43-53.
17. Mollison LC, Stingemore N, Wake RA, et al. Antibiotic resistance in Helicobacter pylori. Med J Aust. 2000;173:521-3.
18. Katelaris PH, Adamthwaite D, Midolo P. Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study. Aliment Pharmacol Ther. 2000;14:751-758.
19. Wolle K, Leodolter A, Malfertheiner P, Konig W. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol. 2002;51:705-9.
20. Oleastro M, Menard A, Santos A, et al. Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J Clin Microbiol. 2003;41:397-402.
21. New Zealand Public Health Report. National surveillance data. New Zealand Public Health Report; 2002;9:22-3.
22. Kato S, Fujimura S, Udagawa H, et al. Antibiotic resistance of Helicobacter pylori strains in Japanese children. J Clin Microbiol. 2002;40:649-53.
23. Wermeille J, Cunningham M, Dederding JP, et al. Failure of Helicobacter pylori eradication: is poor compliance the main cause? Gastroenterol Clin Biol. 2002;26:207-9.